Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|March 29, 2025
Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost TrialSaskia A Cooke, José S A Belderbos, Barbara Stam, et al.
Clinical and Translational Radiation Oncology|September 28, 2018
Long term safety and visibility of a novel liquid fiducial marker for use in image guided radiotherapy of non-small cell lung cancerSteen Riisgaard de Blanck, Jonas Scherman Rydhög, Klaus Richter Larsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 21, 2017
Liquid fiducial marker applicability in proton therapy of locally advanced lung cancerJonas Scherman Rydhög, Rosalind Perrin, Rasmus Irming Jølck, et al.
JTO Clinical and Research Reports|April 9, 2024
Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter StudyAgon Olloni, Carsten Brink, Ebbe Laugaard Lorenzen, et al.
Acta Oncologica (Stockholm, Sweden)|September 5, 2025
Image quality assessment of photon-counting CT for patients with prostate cancer receiving radiotherapyCecilie Valet Henneberg, Weronika Elżbieta Olech, Louis Mathias Dreyer Teller, et al.
JCO Oncology Practice|December 10, 2024
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled TrialRasmus Blechingberg Friis, Helle Pappot, Niels Henrik Hjollund, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
MR-guided stereotactic radiotherapy of infra-diaphragmatic oligometastases: Evaluation of toxicity and dosimetric parametersMette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, et al.
Journal for Immunotherapy of Cancer|July 23, 2026
Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trialRikke Løvendahl Eefsen, Nicklas Juel Spindler, Susann Theile, et al.
BMC Cancer|March 6, 2022
High Intensity Aerobic exercise training and Immune cell Mobilization in patients with lung cancer (HI AIM)-a randomized controlled trialGitte Holmen Olofsson, Marta Kramer Mikkelsen, Anne-Mette Ragle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 29, 2025
1-year efficacy results after MR-guided risk-adapted stereotactic radiotherapy of infra-diaphragmatic oligometastases in a multicenter phase II trialMette van Overeem Felter, Pia Krause Møller, Mirjana Josipovic, et al.
Pageof 4